Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009952 (
febrile convulsions
)
1,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Febrile convulsion
(FC) is the most common neurological disease in children. Cases with seizures that persist for more than 15 minutes or recurrent seizures within the same febrile illness are considered to be atypical and may have a different prognosis.
Neuropeptide Y
(
NPY
), an endogenous anticonvulsant that is widely distributed throughout the central nervous system, including the hippocampus, is known to prevent seizures by increasing the seizure threshold. Based on our previously finding that patients with atypical FC have lower concentrations of
NPY
, we hypothesized that the concentration of
NPY
may play a role in the development of atypical FC. To investigate this hypothesis, we used a radioimmunoassay to measure the plasma
NPY
concentration of 60 children with FC (typical FC, n = 46; atypical FC, n = 14) and 56 age-matched controls. The atypical FC group had significantly lower concentrations of
NPY
than children with typical FC and controls (66.47 +/- 19.11 pmol/L vs. 88.68 +/- 28.50 pmol/L and 86.82 +/- 22.66 pmol/L, respectively). Very low
NPY
levels were found in two patients; one patient (
NPY
level: 44.75 pmol/L) experienced prolonged seizures lasting for up to 1 hour and the other had recurrent seizures (three seizures) during the same febrile illness (
NPY
level: 33.53 pmol/L). These results suggest that patients with inadequate
NPY
inhibitory activity are more susceptible to atypical FC.
...
PMID:Lower plasma neuropeptide Y level in patients with atypical febrile convulsions. 2004 Apr 67